Alternative Gene Splicing is Crucial to Muscle Mass Maintenance
News Jul 12, 2018 | Original Press Release from Baylor College of Medicine
Alternative splicing allows cells to make many different proteins with a limited number of genes. Credit: National Human Genome Research Institute.
Despite the importance that changes in muscle mass have in aging, overall body metabolism and in chronic disease, we still don’t fully understand the mechanisms that contribute to maintaining adult muscle mass.
“A number of cell signaling and metabolic pathways have been studied regarding their involvement in sustaining adult muscle mass, but not alternative splicing,” said Dr. Thomas Cooper, professor of pathology & immunology, of molecular and cellular biology and of molecular physiology and biophysics at Baylor College of Medicine.
Alternative splicing is a cellular mechanism that allows cells to produce many different proteins from a single gene. A gene can be visualized as a short string of ‘beads’ or exons. Each bead codes for a different piece of the final protein. Alternative splicing allows the cell to make different proteins by combining the ‘beads’ in different ways.
The researchers and other groups previously determined that alternative splicing regulators Rbfox1 and Rbfox2 were required for muscle development and function, but Cooper’s group hypothesized that the two proteins worked together, and their combined role in adult muscle had not been studied before.
“To determine whether alternative splicing played a role in sustaining adult muscle mass, we disrupted the process in adult mice by knocking out the genes Rbfox1 and Rbfox2 only in skeletal muscles. Then, we looked at the effect this disruption had in muscles in the animals’ limbs,” said Dr. Ravi Singh, instructor of pathology & immunology at Baylor College of Medicine.
The critical role of alternative splicing
“We observed that the knockout mice rapidly lost about half of their skeletal muscle mass within four weeks,” Singh said. “Two weeks after knocking out the genes Rbfox1 and Rbfox2, hundreds of other genes altered their expression and other genes their alternative splicing, including the capn3 gene, which switched splicing to produce an active form of a protease, an enzyme that degrades proteins.”
“Taking all our observations together, we attributed the loss of muscle mass to an increase in degradation of muscle protein rather than a reduction of protein synthesis,” said Cooper, who also is the S. Donald Greenberg and R. Clarence and Irene H. Fulbright Professor and a member of the Dan L Duncan Comprehensive Cancer Center at Baylor. “The results indicate that the Rbfox splicing regulators, which are highly conserved from the worm C. elegans to humans, are essential for maintaining skeletal muscle mass in adult mice.”
“Our contribution has implications for studies on the role of muscle mass in metabolism and on muscle mass loss in aging and chronic disease,” Singh said.
This article has been republished from materials provided by Baylor College of Medicine. Note: material may have been edited for length and content. For further information, please contact the cited source.
Reference: Park, S., Supek, F., & Lehner, B. (2018). Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits. Nature Communications, 9(1), 2601. https://doi.org/10.1038/s41467-018-04900-7
Working Together Helps Phage Overcome CRISPRNews
Surprising results show that phage join forces to overcome bacteria’s CRISPR -based immune defenses. Improved understanding of the interactions between phage and their bacterial hosts could help advance phage-based therapies and stimulate viral research.READ MORE
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018